← Back to headlines





The Decline of BioNTech, the Pandemic's Vaccine Hero
A report on how BioNTech, the German pharmaceutical company that developed the first approved mRNA COVID-19 vaccine, has seen its fortunes decline six years after its pandemic peak.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Revolut Secures Conditional U.S. National Bank Charter
22m ago

Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
31m ago
Canada’s Trade Surplus Narrows in July Amid Falling Exports
37m ago

Snowflake Stock Soars After AI-Driven Revenue Growth Powers Blowout Quarter
48m ago